Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease)

NCT04345601 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Sars-CoV2
Acute Respiratory Distress Syndrome
COVID-19

Interventions

BIOLOGICAL: Mesenchymal Stromal Cells
OTHER: Supportive Care

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]